Display options
Share it on

Rheumatol Rehabil. 1976 May;15(2):81-6. doi: 10.1093/rheumatology/15.2.81.

Some studies of feprazone.

Rheumatology and rehabilitation

I Haslock, L Burkinshaw, D J Berry, B Donovan, V Wright

PMID: 132695 DOI: 10.1093/rheumatology/15.2.81

Abstract

Feprazone, 200 mg t.d.s., was compared with indomethacin, 25 mg t.d.s. rising to 50 mg t.d.s., in an eight-week double-blind cross-over study in twenty-three patients with active rheumatoid arthritis. Both therapies proved equally efficacious and acceptable. Measurement of the plasma levels of the two drugs showed no consistent correlation between efficacy and plasma concentrations.

Substances

MeSH terms

Publication Types